Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Aerosol Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global aerosol delivery devices market reached a value of US$ 41.45 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 60.14 Billion by 2027 exhibiting a CAGR of 5.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Aerosol delivery devices are used in drug delivery and treating respiratory disorders, such as asthma, obstructive lung diseases, cystic fibrosis, pulmonary arterial hypertension, infectious pulmonary. They lower dosage requirements, reduce systemic adverse effects and improve the ability of patients to self-administer medication. Some of the commonly available aerosol delivery devices are pressurized metered-dose inhalers, nebulizers, and valved holder chambers. At present, smart aerosol drug delivery devices are used in non-respiratory conditions, such as diabetes, analgesia, thyroid disorders, and genetic diseases, due to the advent of novel macromolecular medications.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Aerosol Delivery Devices Market Trends:

The global outbreak of the coronavirus disease (COVID-19) that leads to acute respiratory infections among patients represents one of the key factors driving the need for aerosol delivery devices. These devices assist in treating obstructive airway diseases at home and in healthcare settings. Apart from this, the rising prevalence of chronic respiratory infections due to surging air pollution levels, allergens and occupational risks, and the increasing number of individuals who smoke tobacco and drink is propelling the market growth.  Moreover, a considerable rise in the geriatric population, which is more vulnerable to developing serious health illnesses, is positively influencing the demand for portable inhalation devices that are convenient and economical. Besides this, market players are developing novel aerosol delivery devices that help treat chronic inflammation and infection in the lungs and improve airway clearance in patients with cystic fibrosis (CF). Furthermore, they are offering mini ultrasonic nebulizers and inhalers through e-commerce channels that have automatic memory and are easy to use while traveling. This, in confluence with the escalating demand for personalized drug therapy and the increasing use of online channels for purchasing medical supplies, is driving the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global aerosol delivery devices market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on product, application and distribution channel.

Breakup by Product:

  • Dry Powder Inhalers
    • Single Dose Inhalers
    • Multi Dose Inhalers
  • Metered Dose Inhalers
    • Conventional Pressurized Inhalers
    • Soft Mist Inhalers
  • Nebulizers
    • Jet Nebulizers
    • Ultrasonic Wave Nebulizers
    • Vibrating Mesh Nebulizers
       

Breakup by Application:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Non-Respiratory Diseases
    • Diabetes
    • Analgesia
    • Parkinson’s Disease
       

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Stores
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product, Application, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global aerosol delivery devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global aerosol delivery devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global aerosol delivery devices market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Aerosol Delivery Devices Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Dry Powder Inhalers
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Single Dose Inhalers
           6.1.2.2 Multi Dose Inhalers
        6.1.3 Market Forecast
    6.2    Metered Dose Inhalers
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Conventional Pressurized Inhalers
           6.2.2.2 Soft Mist Inhalers
        6.2.3 Market Forecast
    6.3    Nebulizers
        6.3.1 Market Trends
        6.3.2 Key Segments
           6.3.2.1 Jet Nebulizers
           6.3.2.2 Ultrasonic Wave Nebulizers
           6.3.2.3 Vibrating Mesh Nebulizers
        6.3.3 Market Forecast
7    Market Breakup by Application
    7.1    Asthma
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Chronic Obstructive Pulmonary Disease (COPD)
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Cystic Fibrosis
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Non-Respiratory Diseases
        7.4.1 Market Trends
        7.4.2 Key Segments
           7.4.2.1 Diabetes
           7.4.2.2 Analgesia
           7.4.2.3 Parkinson’s Disease
        7.4.3 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Retail Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Hospital Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    3M Company
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Aerogen
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    GlaxoSmithKline plc
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Johnson & Johnson
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Koninklijke Philips N.V.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Merck & Co. Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Metall Zug AG
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
        14.3.8    Recipharm AB (publ)
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Teva Pharmaceutical Industries Ltd.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Vectura Group plc
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Aerosol Delivery Devices Market: Major Drivers and Challenges
Figure 2: Global: Aerosol Delivery Devices Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Aerosol Delivery Devices Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Aerosol Delivery Devices Market: Breakup by Product (in %), 2021
Figure 5: Global: Aerosol Delivery Devices Market: Breakup by Application (in %), 2021
Figure 6: Global: Aerosol Delivery Devices Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Aerosol Delivery Devices Market: Breakup by Region (in %), 2021
Figure 8: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Aerosol Delivery Devices (Nebulizers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Aerosol Delivery Devices (Nebulizers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Aerosol Delivery Devices (Asthma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Aerosol Delivery Devices (Asthma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Aerosol Delivery Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Aerosol Delivery Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Aerosol Delivery Devices (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Aerosol Delivery Devices (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Aerosol Delivery Devices Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Aerosol Delivery Devices Industry: SWOT Analysis
Figure 78: Global: Aerosol Delivery Devices Industry: Value Chain Analysis
Figure 79: Global: Aerosol Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Aerosol Delivery Devices Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Aerosol Delivery Devices Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Aerosol Delivery Devices Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Aerosol Delivery Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Aerosol Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Aerosol Delivery Devices Market: Competitive Structure
Table 7: Global: Aerosol Delivery Devices Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links